INSMED INC Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
INSMED INC (INSM) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$609.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2012-05-08
- INSMED INC increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2012-03-31 was -$609.00K.
- INSMED INC increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2011-03-31 was -$46.00K.
- INSMED INC increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2011 was $667.00K.
- INSMED INC increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2010 was -$1.13M.
- INSMED INC increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2009 was -$874.00K.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|
| 2012-03-31 | -$609.00K 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $667.00K 10-K · filed 2012-03-13 | |
| 2011-03-31 | -$46.00K 10-Q · filed 2012-05-08 | |
| 2010-12-31 | -$1.13M 10-K · filed 2012-03-13 | |
| 2009-12-31 | -$874.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |